Antimycobacterial cyclic peptide natural products bind and dysregulate stress response chaperones

preprint OA: closed
Full text JSON View at publisher

Abstract

Abstract The protein quality control system is a promising and largely untapped mycobacterial target for the discovery of novel antibiotics. The ClpC1:ClpP1P2 protease is an essential component of the system and is involved in both regulatory and stress-related protein degradation. Several cyclic peptide natural products have been discovered, including ecumicin, the ilamycins and cyclomarin, which bind the ClpC1 chaperone component of the system and possess potent antimycobacterial activity. This has led to significant interest in these molecules, and the ClpC1:ClpP1P2 system more generally, as a bona fide target for the development of new classes of tuberculosis drugs. Utilising cutting edge mass-spectrometry-based proteomics on virulent Mycobacterium tuberculosis H37Rv, we reveal key differences in the mechanism of action for ecumicin, ilamycin E and cyclomarin, with each natural product having distinct effects on the proteome and different consequences for ClpC1 substrate recognition. An additional Clp protein, ClpC2, safeguards the ClpC1:ClpP1P2 complex from obstruction by chaperoning excess unfolded proteins in the event of proteotoxic stress. We show that all three natural products bind ClpC2, with varying affinities, in addition to ClpC1. Notably, we report the significant accumulation of the small heat shock protein, Hsp20, in the presence of ecumicin. A direct binding interaction between Hsp20 and ecumicin is observed that is proposed to stimulate this upregulation. Together, our data reveal that these natural products bind and dysregulate chaperones beyond ClpC1 and dysregulate ClpC1 substrate recognition via distinct mechanisms. This highlights the potential for the development of antimycobacterials that disrupt protein quality control beyond a single protein target.
Full text 17,918 characters · extracted from preprint-html · click to expand
Antimycobacterial cyclic peptide natural products bind and dysregulate stress response chaperones | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Article Antimycobacterial cyclic peptide natural products bind and dysregulate stress response chaperones Richard Payne, Isabel Barter, Max Bedding, Joshua Maxwell, Paige Hawkins, and 6 more This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-5493888/v1 This work is licensed under a CC BY 4.0 License Status: Published Journal Publication published 29 Jan, 2026 Read the published version in Nature Communications → Version 1 posted You are reading this latest preprint version Abstract The protein quality control system is a promising and largely untapped mycobacterial target for the discovery of novel antibiotics. The ClpC1:ClpP1P2 protease is an essential component of the system and is involved in both regulatory and stress-related protein degradation. Several cyclic peptide natural products have been discovered, including ecumicin, the ilamycins and cyclomarin, which bind the ClpC1 chaperone component of the system and possess potent antimycobacterial activity. This has led to significant interest in these molecules, and the ClpC1:ClpP1P2 system more generally, as a bona fide target for the development of new classes of tuberculosis drugs. Utilising cutting edge mass-spectrometry-based proteomics on virulent Mycobacterium tuberculosis H37Rv, we reveal key differences in the mechanism of action for ecumicin, ilamycin E and cyclomarin, with each natural product having distinct effects on the proteome and different consequences for ClpC1 substrate recognition. An additional Clp protein, ClpC2, safeguards the ClpC1:ClpP1P2 complex from obstruction by chaperoning excess unfolded proteins in the event of proteotoxic stress. We show that all three natural products bind ClpC2, with varying affinities, in addition to ClpC1. Notably, we report the significant accumulation of the small heat shock protein, Hsp20, in the presence of ecumicin. A direct binding interaction between Hsp20 and ecumicin is observed that is proposed to stimulate this upregulation. Together, our data reveal that these natural products bind and dysregulate chaperones beyond ClpC1 and dysregulate ClpC1 substrate recognition via distinct mechanisms. This highlights the potential for the development of antimycobacterials that disrupt protein quality control beyond a single protein target. Biological sciences/Chemical biology/Natural products Biological sciences/Chemical biology/Proteomics Proteomics ClpC1 Mycobacterium tuberculosis Ecumicin Ilamycin Cyclomarin Full Text Additional Declarations There is NO Competing Interest. Supplementary Files SuppData1.xlsx Supplementary Dataset 1 SuppData2.xlsx Supplementary Dataset 2 SuppData3.xlsx Supplementary Dataset 3 nrreportingsummaryClpC1NatureCommun.pdf Reporting summary nreditorialpolicychecklistClpC1NatureCommun.pdf Editorial policy checklist ClpC1SuppFiguresTablesMethodsNatureCommunSUBMISSION2011.pdf Supplementary Figures, Tables and Methods Cite Share Download PDF Status: Published Journal Publication published 29 Jan, 2026 Read the published version in Nature Communications → Version 1 posted You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-5493888","acceptedTermsAndConditions":true,"allowDirectSubmit":false,"archivedVersions":[],"articleType":"Article","associatedPublications":[],"authors":[{"id":383252993,"identity":"2ce1d1b6-ad55-47f8-b643-0a4b245b5fec","order_by":0,"name":"Richard Payne","email":"data:image/png;base64,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","orcid":"https://orcid.org/0000-0002-3618-9226","institution":"The University of Sydney","correspondingAuthor":true,"prefix":"","firstName":"Richard","middleName":"","lastName":"Payne","suffix":""},{"id":383252994,"identity":"c06daa28-1687-4dcc-8095-c14bc57b5179","order_by":1,"name":"Isabel Barter","email":"","orcid":"","institution":"The University of Sydney","correspondingAuthor":false,"prefix":"","firstName":"Isabel","middleName":"","lastName":"Barter","suffix":""},{"id":383252995,"identity":"bd42fe55-9701-4985-b6b3-e4627662acc0","order_by":2,"name":"Max Bedding","email":"","orcid":"","institution":"The University of Sydney","correspondingAuthor":false,"prefix":"","firstName":"Max","middleName":"","lastName":"Bedding","suffix":""},{"id":383252996,"identity":"627b6c19-16ce-4da3-be7d-dcc1a16dc86d","order_by":3,"name":"Joshua Maxwell","email":"","orcid":"","institution":"The University of Sydney","correspondingAuthor":false,"prefix":"","firstName":"Joshua","middleName":"","lastName":"Maxwell","suffix":""},{"id":383252997,"identity":"c05781f0-7d63-48fb-9521-46fc177f7fbd","order_by":4,"name":"Paige Hawkins","email":"","orcid":"","institution":"The University of Sydney","correspondingAuthor":false,"prefix":"","firstName":"Paige","middleName":"","lastName":"Hawkins","suffix":""},{"id":383252998,"identity":"7475b4bb-c67c-4314-b6fa-f546e86ab4dd","order_by":5,"name":"Xiaonan Wang","email":"","orcid":"","institution":"The University of Sydney","correspondingAuthor":false,"prefix":"","firstName":"Xiaonan","middleName":"","lastName":"Wang","suffix":""},{"id":383252999,"identity":"2129f09c-821f-4860-9b74-922e452dbd7b","order_by":6,"name":"Diana Quan","email":"","orcid":"","institution":"University of Sydney","correspondingAuthor":false,"prefix":"","firstName":"Diana","middleName":"","lastName":"Quan","suffix":""},{"id":383253000,"identity":"8f73cbf2-6d53-4067-a18d-06b1b2980654","order_by":7,"name":"Sabryna Junker","email":"","orcid":"https://orcid.org/0000-0001-9846-4505","institution":"Research Institute of Molecular Pathology","correspondingAuthor":false,"prefix":"","firstName":"Sabryna","middleName":"","lastName":"Junker","suffix":""},{"id":383253001,"identity":"93754bd7-c277-446c-be43-36be898ef8bf","order_by":8,"name":"Tim Clausen","email":"","orcid":"https://orcid.org/0000-0003-1582-6924","institution":"Research Institute of Molecular Pathology – IMP","correspondingAuthor":false,"prefix":"","firstName":"Tim","middleName":"","lastName":"Clausen","suffix":""},{"id":383253002,"identity":"0ad37799-6a52-4210-984e-98d4324ed5ee","order_by":9,"name":"Warwick Britton","email":"","orcid":"https://orcid.org/0000-0001-6721-9646","institution":"Centenary Institute, The University of Sydney","correspondingAuthor":false,"prefix":"","firstName":"Warwick","middleName":"","lastName":"Britton","suffix":""},{"id":383253003,"identity":"2c7e6032-0924-48d0-aab8-a9e72772ec2e","order_by":10,"name":"Mark Larance","email":"","orcid":"https://orcid.org/0000-0002-8579-2267","institution":"University of Sydney","correspondingAuthor":false,"prefix":"","firstName":"Mark","middleName":"","lastName":"Larance","suffix":""}],"badges":[],"createdAt":"2024-11-21 01:45:12","currentVersionCode":1,"declarations":"","doi":"10.21203/rs.3.rs-5493888/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-5493888/v1","draftVersion":[],"editorialEvents":[{"content":"https://doi.org/10.1038/s41467-026-68423-2","type":"published","date":"2026-01-29T05:00:00+00:00"}],"editorialNote":"","failedWorkflow":false,"files":[{"id":102901137,"identity":"a7e87606-2b8f-4407-a92e-bf3a90a58c2f","added_by":"auto","created_at":"2026-02-18 08:10:34","extension":"pdf","order_by":1,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":1414936,"visible":true,"origin":"","legend":"Article File","description":"","filename":"ClpC1manuscriptNatureCommunSUBMISSION20112024.pdf","url":"https://assets-eu.researchsquare.com/files/rs-5493888/v1_covered_21d02e88-687c-4b0c-aee8-8a1690051509.pdf"},{"id":70149711,"identity":"7e5fe7a7-8265-4fc6-af72-73c3b25c9d31","added_by":"auto","created_at":"2024-11-29 01:56:35","extension":"xlsx","order_by":1,"title":"","display":"","copyAsset":false,"role":"supplement","size":1309905,"visible":true,"origin":"","legend":"Supplementary Dataset 1","description":"","filename":"SuppData1.xlsx","url":"https://assets-eu.researchsquare.com/files/rs-5493888/v1/3624d7592958966b1b28d97e.xlsx"},{"id":70149244,"identity":"e4823d40-a8f8-4a34-a120-a20a79f32ab0","added_by":"auto","created_at":"2024-11-29 01:48:36","extension":"xlsx","order_by":2,"title":"","display":"","copyAsset":false,"role":"supplement","size":90568,"visible":true,"origin":"","legend":"Supplementary Dataset 2","description":"","filename":"SuppData2.xlsx","url":"https://assets-eu.researchsquare.com/files/rs-5493888/v1/ecc8d5f2d97c9d88f818653e.xlsx"},{"id":70149241,"identity":"5d4f7c55-33dc-4af7-b157-1c170397cdc0","added_by":"auto","created_at":"2024-11-29 01:48:35","extension":"xlsx","order_by":3,"title":"","display":"","copyAsset":false,"role":"supplement","size":137519,"visible":true,"origin":"","legend":"Supplementary Dataset 3","description":"","filename":"SuppData3.xlsx","url":"https://assets-eu.researchsquare.com/files/rs-5493888/v1/2bac806952ce91ba4ff04a31.xlsx"},{"id":70149248,"identity":"2df26211-d1f1-4ef7-a3a2-2a81b5c7a796","added_by":"auto","created_at":"2024-11-29 01:48:36","extension":"pdf","order_by":4,"title":"","display":"","copyAsset":false,"role":"supplement","size":1665625,"visible":true,"origin":"","legend":"\u003cp\u003eReporting summary\u003c/p\u003e","description":"","filename":"nrreportingsummaryClpC1NatureCommun.pdf","url":"https://assets-eu.researchsquare.com/files/rs-5493888/v1/6c1933efbe70f4973fc31b1f.pdf"},{"id":70149249,"identity":"8741caae-85dd-4f78-aecb-235b46ed348e","added_by":"auto","created_at":"2024-11-29 01:48:36","extension":"pdf","order_by":5,"title":"","display":"","copyAsset":false,"role":"supplement","size":1682180,"visible":true,"origin":"","legend":"\u003cp\u003eEditorial policy checklist\u003c/p\u003e","description":"","filename":"nreditorialpolicychecklistClpC1NatureCommun.pdf","url":"https://assets-eu.researchsquare.com/files/rs-5493888/v1/64fa4057800bbfffc173ac1f.pdf"},{"id":70149713,"identity":"711bd71e-da49-431e-954e-0e3558f91d5b","added_by":"auto","created_at":"2024-11-29 01:56:36","extension":"pdf","order_by":6,"title":"","display":"","copyAsset":false,"role":"supplement","size":2798015,"visible":true,"origin":"","legend":"\u003cp\u003eSupplementary Figures, Tables and Methods\u003c/p\u003e","description":"","filename":"ClpC1SuppFiguresTablesMethodsNatureCommunSUBMISSION2011.pdf","url":"https://assets-eu.researchsquare.com/files/rs-5493888/v1/55c8b248d373c77f8185fc71.pdf"}],"financialInterests":"There is \u003cb\u003eNO\u003c/b\u003e Competing Interest.","formattedTitle":"Antimycobacterial cyclic peptide natural products bind and dysregulate stress response chaperones","fulltext":[],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":false,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":true,"hideJournal":false,"highlight":"","institution":"","isAcceptedByJournal":true,"isAuthorSuppliedPdf":true,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":true,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"[email protected]","identity":"nature-portfolio","isNatureJournal":true,"hasQc":false,"allowDirectSubmit":false,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"","title":"Nature Portfolio","twitterHandle":"","acdcEnabled":false,"dfaEnabled":false,"editorialSystem":"ejp","reportingPortfolio":"","inReviewEnabled":true,"inReviewRevisionsEnabled":false},"keywords":"Proteomics, ClpC1, Mycobacterium tuberculosis, Ecumicin, Ilamycin, Cyclomarin","lastPublishedDoi":"10.21203/rs.3.rs-5493888/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-5493888/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"The protein quality control system is a promising and largely untapped mycobacterial target for the discovery of novel antibiotics. The ClpC1:ClpP1P2 protease is an essential component of the system and is involved in both regulatory and stress-related protein degradation. Several cyclic peptide natural products have been discovered, including ecumicin, the ilamycins and cyclomarin, which bind the ClpC1 chaperone component of the system and possess potent antimycobacterial activity. This has led to significant interest in these molecules, and the ClpC1:ClpP1P2 system more generally, as a bona fide target for the development of new classes of tuberculosis drugs. Utilising cutting edge mass-spectrometry-based proteomics on virulent Mycobacterium tuberculosis H37Rv, we reveal key differences in the mechanism of action for ecumicin, ilamycin E and cyclomarin, with each natural product having distinct effects on the proteome and different consequences for ClpC1 substrate recognition. An additional Clp protein, ClpC2, safeguards the ClpC1:ClpP1P2 complex from obstruction by chaperoning excess unfolded proteins in the event of proteotoxic stress. We show that all three natural products bind ClpC2, with varying affinities, in addition to ClpC1. Notably, we report the significant accumulation of the small heat shock protein, Hsp20, in the presence of ecumicin. A direct binding interaction between Hsp20 and ecumicin is observed that is proposed to stimulate this upregulation. Together, our data reveal that these natural products bind and dysregulate chaperones beyond ClpC1 and dysregulate ClpC1 substrate recognition via distinct mechanisms. This highlights the potential for the development of antimycobacterials that disrupt protein quality control beyond a single protein target.","manuscriptTitle":"Antimycobacterial cyclic peptide natural products bind and dysregulate stress response chaperones","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2024-11-29 01:48:30","doi":"10.21203/rs.3.rs-5493888/v1","editorialEvents":[],"status":"published","journal":{"display":true,"email":"[email protected]","identity":"nature-communications","isNatureJournal":true,"hasQc":false,"allowDirectSubmit":false,"externalIdentity":"NCOMMS","sideBox":"Learn more about [Nature Communications](http://www.nature.com/ncomms/)","snPcode":"","submissionUrl":"https://mts-ncomms.nature.com/","title":"Nature Communications","twitterHandle":"","acdcEnabled":true,"dfaEnabled":true,"editorialSystem":"ejp","reportingPortfolio":"Nature Communications","inReviewEnabled":true,"inReviewRevisionsEnabled":false}}],"origin":"","ownerIdentity":"a46ba3ef-b085-4cf9-a675-60428a2ad40e","owner":[],"postedDate":"November 29th, 2024","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"published-in-journal","subjectAreas":[{"id":40820779,"name":"Biological sciences/Chemical biology/Natural products"},{"id":40820780,"name":"Biological sciences/Chemical biology/Proteomics"}],"tags":[],"updatedAt":"2026-02-18T08:10:14+00:00","versionOfRecord":{"articleIdentity":"rs-5493888","link":"https://doi.org/10.1038/s41467-026-68423-2","journal":{"identity":"nature-communications","isVorOnly":false,"title":"Nature Communications"},"publishedOn":"2026-01-29 05:00:00","publishedOnDateReadable":"January 29th, 2026"},"versionCreatedAt":"2024-11-29 01:48:30","video":"","vorDoi":"10.1038/s41467-026-68423-2","vorDoiUrl":"https://doi.org/10.1038/s41467-026-68423-2","workflowStages":[]},"version":"v1","identity":"rs-5493888","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-5493888","identity":"rs-5493888","version":["v1"]},"buildId":"qtupq5eGEP_6zYnWcrvyt","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: preprint-html

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2024) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00